” As such, we can not advise the routine use of hydroxychloroquine amongst [health care workers] to prevent COVID-19,” researchers concluded.
In July, The Food and Drug Administration (FDA) withdrew the emergency situation usage permission for both chloroquine and hydroxychloroquine due to major security issues.
Medical professionals have alerted that the drugs can trigger severe heart issues, however the FDA had actually formerly allowed their usage for hospitalized patients and throughout medical trials.
The research study, released Wednesday in the journal JAMA Internal Medicine, was carried out at two urban hospitals between April 9 and July 13 amongst 132 full-time healthcare employees exposed to the virus. The trial was ended early.
Four of the 64 health care employees who were randomly offered hydroxychloroquine ended up testing favorable for COVID-19 and 4 of the 61 health care workers who were offered a placebo evaluated favorable.
Amongst those 8 individuals who tested positive, six established viral symptoms. None required hospitalization and they all medically recuperated from the disease, according to the research study.
The findings of the newly launched study appear similar to what was reported in a June study in the New England Journal of Medicine, which found that hydroxychloroquine did not prevent health problem when used within four days of being exposed..
Trumps promo of the drug has actually caused shortages for people that require it for other conditions. Hydroxychloroquine, which was at first authorized as an anti-malaria drug, is also utilized to treat lupus and rheumatoid arthritis..
Trump repeatedly promoted the drug as a possible miracle treatment for the infection. He stated in May that he had been taking hydroxychloroquine, in mix with zinc, as a method to avoid getting COVID-19.
A new study has discovered that hydroxychloroquine, the anti-malaria drug that President TrumpDonald John TrumpTrump indications costs avoiding shutdown after brief financing lapse Privacy, civil rights groups require transparency from Amazon on election information breaches Facebook takes down Trump project advertisements tying refugees to coronavirus MORE stated he required to ward off the coronavirus, did not avoid COVID-19 amongst healthcare employees.
Some individuals were offered 600 mg daily doses of hydroxychloroquine, while others were offered a placebo for 8 weeks.
” There was no considerable distinction in infection rates in individuals randomized to receive hydroxychloroquine compared to placebo,” the researchers from the University of Pennsylvania wrote.